UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
85 hedge funds and large institutions have $109M invested in Unity Biotechnology in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
26% more call options, than puts
Call options by funds: $594K | Put options by funds: $472K
8% more funds holding
Funds holding: 79 → 85 (+6)
0.17% more ownership
Funds ownership: 3.78% → 3.95% (+0.17%)
Holders
85
Holding in Top 10
3
Calls
$594K
Puts
$472K
Top Buyers
| 1 | +$1.49M | |
| 2 | +$1.47M | |
| 3 | +$938K | |
| 4 |
CCM
CAAS Capital Management
New York
|
+$865K |
| 5 |
JPMorgan Chase & Co
New York
|
+$475K |
Top Sellers
| 1 | -$1.41M | |
| 2 | -$1.02M | |
| 3 | -$361K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$195K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$188K |